Retraction: Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes (Journal of General Virology (2021) 86 (3047-3053) DOI: 10.1099/vir.0.81132-0);Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes

Journal of General Virology

Volumn 86, Issue 11, 2005, Pages 3047-3053

  Hazari, Sidhartha ^a   Patil, Asha ^a   Joshi, Virendra ^a   Sullivan, Deborah E ^a   Fermin, Cesar D ^a   Garry, Robert F ^a   Elliot, Richard M ^b   Dash, Srikanta ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CYTOKINE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RNA DEGRADATION; RNA TRANSLATION; SEQUENCE ANALYSIS;

HEPATITIS C VIRUS;

EID: 27644467588     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/JGV.0.001600     Document Type: Erratum

References (43)

1. Ali, N., Pruijn, G. J., Kenan, D. J., Keene, J. D. & Siddiqui, A. (2000). Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem 275, 27531-27540.
2. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A. & Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341, 556-562.
3. Brown, E. A., Zhang, H., Ping, L. H. & Lemon, S. M. (1992). Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20, 5041-5045.
4. Bukh, J., Miller, R. H. & Purcell, R. H. (1995). Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15, 41-63.
5. Cao, Z., Henzel, W. J. & Gao, X. (1996). IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131.
6. Castet, V., Fournier, C., Soulier, A., Brillet, R., Coste, J., Larrey, D., Dhumeaux, D., Maurel, P. & Pawlostsky, J. M. (2002). Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J Virol 76, 8189-8199.
7. Chamberlain, R. W., Adams, N., Saeed, A. A., Simmonds, P. & Elliott, R. M. (1997a). Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78, 1341-1347.
8. Chamberlain, R. W., Adams, N. J., Taylor, L. A., Simmonds, P. & Elliott, R. M. (1997b). The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa. Biochem Biophys Res Commun 236, 44-49.
9. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
10. Collier, A. J., Tang, S. & Elliott, R. M. (1998). Translation efficiencies of the 5′ untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel dicistronic reporter assay system. J Gen Virol 79, 2359-2366.
11. Daniels, H. M., Meager, A., Eddleston, A. L., Alexander, G. J. & Williams, R. (1990). Spontaneous production of tumor necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet 335, 875-877.
12. Dasgupta, A., Das, S., Izumi, R., Venkatesan, A. & Barat, B. (2004). Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. FEMS Microbiol Lett 234, 189-199.
13. Dash, S., Prabhu, R., Hazari, S. & 7 other authors (2005). Interferons alpha, beta and gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site mediated translation. Liver Int 25, 1-15.
14. Dumoulin, F. L., Leifeld, L., Honecker, U., Sauerbruch, T. & Spengler, U. (1999). Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C. J Infect Dis 180, 1704-1708.
15. Fried, M. W., Shiffman, M. L., Reddy, K. R. & 11 other authors (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347, 975-982.
16. Hadziyannis, S. J., Sette, H., Jr, Morgan, T. R. & 11 other authors (for the PEGASYS International Study Group) (2004). Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140, 346-355.
17. Han, J.-Q. & Barton, D. J. (2002). Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8, 512-525.
18. Honda, M., Brown, E. A. & Lemon, S. M. (1996). Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 10, 955-968.
19. Inchauspe, G., Zebedee, S., Lee, D. H., Sugitani, M., Nasoff, M. & Prince, A. M. (1991). Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A 88, 10292-10296.
20. Kamoshita, N., Tsukiyama-Kohara, K., Kohara, M. & Nomoto, A. (1997). Genetic analysis of internal ribosome entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology 233, 9-18.
21. Kato, J., Kato, N., Moriyama, M., Goto, T., Taniguchi, H., Shiratori, Y. & Omata, M. (2002). Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. J Infect Dis 186, 155-163.
22. Kozak, M. (2003). Alternative ways to think about mRNA sequences and proteins that appear to promote internal initiation of translation. Gene 318, 1-23.
23. Lau, J. Y., Davis, G. L., Prescott, L. E., Maertens, G., Lindsay, K. L., Qian, K. & Mizokami, M. (1996). Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seem at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 124, 868-876.
24. Liu, S., Yu, Y., Zhang, M., Wang, W. & Cao, X. (2001). The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells. J Immunol 166, 5407-5415.
25. Mahoney, K., Tedeschi, V., Maertens, G., Di Bisceglie, A. M., Vergalla, J., Hoofnagle, J. H. & Sallie, R. (1994). Genetic analysis of hepatitis C virus in American patients. Hepatology 20, 1405-1411.
26. Manns, M. P., McHutchison, J. G., Gordon, S. C. & 7 other authors (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965.
27. Pawlotsky, J. M. (2000). Hepatitis C virus resistance to antiviral therapy. Hepatology 32, 889-896.
28. Prabhu, R., Joshi, V., Garry, R. F., Bastian, F., Haque, S., Regenstein, F., Thung, S. & Dash, S. (2004). Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. Exp Mol Pathol 76, 242-252.
29. Qi, Z. T., Kalkeri, G., Hanible, J., Prabhu, R., Bastian, F., Garry, R. F. & Dash, S. (2003). Stem-loop structures II-IV of the 5′ untranslated sequences are required for the expression of the full-length hepatitis C virus genome. Arch Virol 148, 449-467.
30. Reed, K. E. & Rice, C. M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing and protein properties. Curr Top Microbiol Immunol 242, 55-84.
31. Reynolds, J. E., Kaminski, A., Carroll, A. R., Clarke, B. E., Rowlands, D. J. & Jackson, R. J. (1996). Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon. RNA 2, 867-878.
32. Robertson, B., Myers, G., Howard, C. & 14 other authors (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 2493-2503.
33. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547-6549.
34. Saiz, J. C., Lopez de Quinto, S., Ibarrola, N., Lopez-Labrador, F. X., Sanchez-Tapias, J. M., Rodes, J. & Martinez-Salas, E. (1999). Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients. Arch Virol 144, 215-229.
35. Shimazaki, T., Honda, M., Kaneko, S. & Kobayashi, K. (2002). Inhibition of internal ribosome entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology 35, 199-208.
36. Simmonds, P. (2004). Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85, 3173-3188.
37. Simmonds, P., Mellor, J., Sakuldamrongpanich, T., Nuchaprayoon, C., Tanprasert, S., Holmes, E. C. & Smith, D. B. (1996). Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 77, 3013-3024.
38. Tang, S., Collier, A. J. & Elliott, R. M. (1999). Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5′ untranslated region (5′UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5′UTR sequence. J Virol 73, 2359-2364.
39. Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nolchen, B., Judmaier, G. & Huber, C. (1992). Serum levels of cytokines in chronic liver diseases. Gastroenterology 103, 264-274.
40. Tokita, H., Okamoto, H., Luengrojanakul, P., Vareesangthip, K., Chainuvati, T., Iizuka, H., Tsuda, F., Miyakawa, Y. & Mayumi, M. (1995). Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 76, 2329-2335.
41. Tsukiyama-Kohara, K., Iizuka, N., Kohara, M. & Nomoto, A. (1992). Internal ribosome entry site within hepatitis C virus RNA. J Virol 66, 1476-1483.
42. Wang, T. H., Rijnbrand, R. C. & Lemon, S. M. (2000). Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol 74, 11347-11358.
43. Zeuzem, S. (2000). Treatment of chronic hepatitis C virus infection in patients with cirrhosis. J Viral Hepat 7, 327-334.